← Alle Unternehmen
AiMorphous Health
Über das Unternehmen
Thrombosis is the #1 cause of death and debilitation. It is initiated by the blood activities related to inflammaging, a key contributor to inflammation and aging. Aimorphous Health develops blood diagnostics that delivers monitoring of blood activities leading to thrombosis, inflammation and aging. By utilizing AI and breakthrough blood biomarkers, the device mediates the monitoring of cryptic biological activities so that people can be informed of their inflammaging activity, have better cardiovascular and general health, and achieve longevity through evidence-based health monitoring. It aims to reduce massively the mortality and the lost of quality live due to inflammaging and thrombosis.